Entry Point Capital, LLC Sutro Biopharma, Inc. Put Options Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding STRO
# of Institutions
122Shares Held
53.3MCall Options Held
7.8KPut Options Held
2.4K-
Suvretta Capital Management, LLC New York, NY5.78MShares$22.5 Million1.4% of portfolio
-
Black Rock Inc. New York, NY5.7MShares$22.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.74MShares$18.4 Million0.01% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.1MShares$15.9 Million3.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.02MShares$11.8 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $203M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...